“A REVIEW ON RECENT STUDY OF COVID-19 AT PRESESNT SCENARIO”

Authors

Devendra Singh Lodhi, Sager Institute of Pharmacy & Technology (SIPTec), Opposite International Airport, JaipurRoad, Gandhi Nager,Bhopal,(M.P)-462036

Dr. Nirmal Dongre, Institute of Pharmaceutical Sciences (S.A.G.E, University, Kailod Kartal, By-Pass Road, Indor, Madhya Pradesh-452020

Abstract

The new coronavirus, now known as Covid-19, was first encountered in November 2019, and has gone on to affect over 200000 people in over 150 countries around the globe, causing more than 100000 deaths. The virus can cause pneumonia-like symptoms. Those who have fallen ill are reported to suffer coughs, fever and breathing difficulties. In severe cases there can be organ failure. As this is viral pneumonia, antibiotics are of no use. The antiviral drugs we have against flu will not work. If people are admitted to hospital, they may get support for their lungs and other organs, as well as fluids. Recovery will depend on the strength of their immune system. Many of those who have died were vulnerable because of existing underlying health conditions. The name Covid-19 was announced on 11 February by the World Health Organization. The director general, Tedros Adhanom Ghebreyesus, said: “We had to find a name that did not refer to a geographical location, an animal, an individual or group of people, and which is also pronounceable and related to the disease. Having a name matters to prevent the use of other names that can be inaccurate or stigmatizing.